Reporting Manager
Sumitomo Mitsui Trust Group, Inc.
Symbol
TXG
Shares outstanding
111,370,167 shares
Disclosed Ownership
6,013,989 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
31 Jul 2025, 06:07:35 UTC
Date of event
30 Jun 2025
Previous filing
25 Apr 2025
Next filing
27 Oct 2025

Quoteable Key Fact

"Sumitomo Mitsui Trust Group, Inc. disclosed 5.4% ownership in 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG) on 30 Jun 2025."

Quick Takeaways

  • Sumitomo Mitsui Trust Group, Inc. filed SCHEDULE 13G for 10x Genomics, Inc. Class A common stock, par value $0.00001 per share (TXG).
  • Disclosed ownership: 5.4%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 25 Apr 2025.
  • Current filing was accepted on 31 Jul 2025, 06:07.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sumitomo Mitsui Trust Group, Inc. 5.4% 6,013,989 0 6,013,989 /s/ Hideaki Takamiya Head of Business Regulatory Compliance
Nikko Asset Management Co., Ltd. 5.4% 6,009,653 0 6,009,653 /s/ Atsushi Ohya Head of Business Regulatory Compliance
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .